Ph.D. candidate Roshan Chikarmane identifies key drivers of rising drug prices and introduces corresponding interventions that are being undertaken by business leaders to shift industry trends toward more affordable health care.
pharmaceuticals
The Biopharma Startup: A Heart-Pounding Venture
Posted by | Perspectives in ResearchHere’s how a group of passionate thinkers turned scholarly insights into therapies that could help millions of patients with heart failure.
The Rising Cost of Pharmaceuticals
Posted by | Perspectives in ResearchLast weekend, my husband and I visited our local pharmacy to pick up a prescription refill. The pharmacist chatted with us cheerfully as she rang us up at the cash register. Suddenly, her typing stopped. “Wow,” she finally said. “This is expensive.” The small pill bottle sat in her palm as she read off the […]
Clinical trial to target cancer drugs to gene mutations for individualized therapy
Posted by | Perspectives in ResearchImagine a scenario where a patient comes into the clinic with a suspected cancer. The clinician not only confirms that the patient does indeed have cancer, but also identifies a specific gene abnormality that is driving the tumor. Without hesitating, the doctor prescribes a cancer drug that specifically targets the gene mutation responsible for the […]